Fingerprint
Dive into the research topics of 'Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically